Search Results
Found 1 results
510(k) Data Aggregation
(162 days)
ELEOS Limb Salvage System with BioGrip
ELEOSTM Limb Salvage System Hip Components:
Indicated for use in total hip arthroplasty for reduction or relief of pain and/or improved hip function in skeletally mature patients with the following conditions :
-
Non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis, ankylosis, protrusion acetabuli. and painful hip dysplasia;
-
Inflammatory degenerative joint disease such as rheumatoid arthritis;
-
Correction of functional deformity
-
Revision procedures where other treatments or devices have failed; and,
-
Treatment of fractures that are unmanageable using other techniques.
Limb salvage system is also indicated for procedures where radical resection and replacement of the proximal, distal and or total femur is required with the following conditions:
-
Patients suffering from severe arthropathy of the hip that does not respond to any conservative therapy or better alternative surgical treatment:
-
Surgical intervention for severe trauma, revision hip arthroplasties, and/or Oncology indications.
-
- Metastatic diseases
ELEOSTM Limb Salvage System Knee Components:
- Metastatic diseases
Indicated for cemented use in knee arthroplasty for reduction or relief of pain and/or improved knee function in skeletally mature patients with the following conditions:
-
Non-inflammatory degenerative joint disease including osteoarthritis, or avascular necrosis;
-
Inflammatory degenerative joint disease including rheumatoid arthritis;
-
Correction of functional deformity;
-
Revision procedures where other treatments or devices have failed; and
-
Treatment of fractures that are unmanageable using other techniques.
Limb salvage system is also indicated for procedures where radical resection and replacement of the proximal tibia is required with the following conditions:
-
Patients suffering from severe arthropathy of the knee that does not respond to any conservative therapy or better alternative surgical treatment;
-
Surgical intervention for severe trauma, revision knee arthroplasties, and/or Oncology indications.
-
Metastatic diseases
The Onkos Surgical ELEOS™ Limb Salvage System consists of components that are used in the reconstruction of the lower limb. The reconstruction are proximal femur, distal femur, total femur, proximal tibia, and hinged knee. The ELEOS Limb Salvage components are femoral head, proximal femur, mid-section, stem, distal hinge femur, tibial hinge assembly, axial pin, tibial poly spacer, tibial sleeve, male mid-section, resurfacing hinge femur, and proximal tibia, optional components include modular collars, patella, stem extensions, tibial wedges and augments. Instrumentation is provided non-sterile in surgical trays which are to be re-processed per the validated instructions stated below.
The provided text is a 510(k) summary for a medical device (ELEOS Limb Salvage System with BioGrip) seeking FDA clearance. This type of submission relies on demonstrating substantial equivalence to a legally marketed predicate device, rather than proving novel performance against specific acceptance criteria through a clinical study.
Therefore, the document does not contain the acceptance criteria or a study designed to prove the device meets those criteria in the way you've outlined for a clinical performance study of, for example, an AI algorithm.
Instead, the document details performance data provided in support of substantial equivalence to a predicate device. This data focuses on mechanical and biocompatibility testing to ensure the new device (a line extension with modular collars and porous technology) is as safe and effective as the existing, cleared predicate device.
Here's a breakdown of what is available based on your request, with an explanation of why other points are not applicable in this context:
1. Table of Acceptance Criteria and Reported Device Performance
As this is a 510(k) submission based on substantial equivalence, there isn't a direct "acceptance criteria" table with specific performance metrics (like sensitivity/specificity for an AI algorithm) that the device must meet to prove its clinical utility. Instead, the performance data provided demonstrates that the device performs similarly or better mechanically and is biocompatible compared to predicate devices, adhering to recognized standards.
Biocompatibility Testing:
Acceptance Criteria (General Goal) | Reported Device Performance |
---|---|
Biocompatible for permanent contact | Passed tests per ISO 10993 series and ANSI/AAMI ST72 for bacterial endotoxins. |
Endotoxin levels within limits | Met 20 endotoxin units (EU)/device limit for implanted medical devices. |
Mechanical Testing:
Acceptance Criteria (General Goal) | Reported Device Performance |
---|---|
Equivalent mechanical properties to predicate | Completed testing according to ASTM F1044, F1147, F1160, F1854, F1978, ISO 7206-4, and ISO 13179-1:2014. Results support substantial equivalence to predicate. |
Adequate strength and durability | Implicitly demonstrated by passing the listed ASTM and ISO standards for orthopedic implants. The specific numerical results (e.g., shear strength values) are not provided in this summary. |
2. Sample Size Used for the Test Set and Data Provenance
This information is not applicable in the context of this 510(k) submission. The "test set" in this case refers to the physical device components subjected to laboratory testing. The document does not describe a clinical study with patients or data from medical records.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
This information is not applicable. Ground truth, in the sense of expert consensus on clinical diagnoses or outcomes, is not established for the mechanical and biocompatibility tests performed. These tests rely on standardized protocols and measurements, not expert interpretation of clinical data.
4. Adjudication Method for the Test Set
This information is not applicable. Adjudication methods like 2+1 or 3+1 are used in clinical studies to resolve discrepancies in expert interpretations of data. The performance analyses presented here are laboratory-based.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs. Without AI Assistance
This information is not applicable. This submission is for a physical orthopedic implant system, not an AI algorithm. No MRMC study or AI assistance is mentioned.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
This information is not applicable. This submission is for a physical orthopedic implant system, not an algorithm.
7. The Type of Ground Truth Used
For biocompatibility, the "ground truth" is defined by the toxicological characteristics and cellular responses measured against established ISO standards.
For mechanical testing, the "ground truth" is defined by the physical limits and properties established in the ASTM and ISO standards for orthopedic implants.
8. The Sample Size for the Training Set
This information is not applicable. There is no "training set" in the context of this device's development as it is not an AI/machine learning device. The design and testing are based on engineering principles and material science.
9. How the Ground Truth for the Training Set Was Established
This information is not applicable for the same reasons as point 8.
Ask a specific question about this device
Page 1 of 1